{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05776914",
            "orgStudyIdInfo": {
                "id": "22-005385"
            },
            "organization": {
                "fullName": "Mayo Clinic",
                "class": "OTHER"
            },
            "briefTitle": "Fecal Microbiota Transplantation for IBS",
            "officialTitle": "Efficacy and Safety of Proteolytic Activity-Guided Fecal Microbiota Transplantation for Irritable Bowel Syndrome (PRAGMAT Trial)",
            "therapeuticArea": [
                "Rare Diseases",
                "Other"
            ],
            "study": "fecal-microbiota-transplantation-for-ibs"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-09",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-03-01",
            "studyFirstSubmitQcDate": "2023-03-17",
            "studyFirstPostDateStruct": {
                "date": "2023-03-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-09",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Madhusudan (Madhu) Grover, MBBS",
                "investigatorTitle": "Regulatory Sponsor and Principal Investigator",
                "investigatorAffiliation": "Mayo Clinic"
            },
            "leadSponsor": {
                "name": "Madhusudan (Madhu) Grover, MBBS",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to learn the efficacy and safety of fecal microbiota transplantation (FMT) using stool from a donor with low proteolytic activity and containing the bacteria Alistipes putredinis in patients with post-infection irritable bowel syndrome (PI-IBS) and high proteolytic activity. Proteolytic activity is the breakdown of proteins into smaller polypeptides or amino acids."
        },
        "conditionsModule": {
            "conditions": [
                "Irritable Bowel Syndrome",
                "Diarrhea"
            ],
            "keywords": [
                "Post-infection irritable bowel syndrome with diarrheal",
                "Post-infection irritable bowel syndrome with mixed symptoms"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 43,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Donor Fecal Microbiota Transplantation Group",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects will receive a fecal microbiota transplantation (FMT) using stool from a donor",
                    "interventionNames": [
                        "Biological: Donor Fecal Microbiota Transplantation"
                    ]
                },
                {
                    "label": "Autologous Fecal Microbiota Transplantation Group",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Subjects will receive a fecal microbiota transplantation (FMT) using their own stool",
                    "interventionNames": [
                        "Biological: Autologous Fecal Microbiota Transplantation"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "Donor Fecal Microbiota Transplantation",
                    "description": "Single fecal microbiota transplantation using 50 gm of freeze-thawed donor stool",
                    "armGroupLabels": [
                        "Donor Fecal Microbiota Transplantation Group"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Autologous Fecal Microbiota Transplantation",
                    "description": "Single fecal microbiota transplantation using 50 gm of stool collected from the same individual",
                    "armGroupLabels": [
                        "Autologous Fecal Microbiota Transplantation Group"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percentage of responders",
                    "description": "Number of subjects receiving the donor fecal microbiota transplantation identified as a responder defined as a decrease of \u226550 points in Irritable Bowel Syndrome Symptom Severity Score (IBS-SSS) from baseline.\n\nThe Irritable Bowel Syndrome Symptom Severity Score scale has a possible range of scores from 0-500. Mild cases are classified as a score of 75-175, moderate cases are classified as a score of 175-300, and severe cases are classified as a score of \\>300.",
                    "timeFrame": "12 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in level of fecal proteolytic activity",
                    "description": "The level of fecal proteolytic activity will be measured at baseline and again at 12 weeks. The proteolytic activity is measured using a standardized FITC Casein assay that relies on the activity of proteases in the sample to digest casein protein.",
                    "timeFrame": "Baseline, 12 weeks"
                },
                {
                    "measure": "Changes in in vivo excretion of 2-24 hr lactulose excretion",
                    "description": "Measured by permeability testing",
                    "timeFrame": "Baseline, 12 weeks"
                },
                {
                    "measure": "Number of weekly responders",
                    "description": "Number of subjects to meet responder criteria of \u226530% decrease in average of worst abdominal pain in past 24 hours plus \u226550% decrease in the number of days per week with at least one stool that has a consistency of Type 6 or 7 (compared with baseline)",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Global Adequate Relief Questionnaire",
                    "description": "Number of subjects to report adequate relief of IBS symptoms, measured by answering yes to question \"In the past 7 days have you had adequate relief of your IBS symptoms?\"",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Alistipes putredinis proportion post-FMT",
                    "description": "Number of subject to have the bacteria Alistipes putredinis in stool sample after fecal microbiota transplantation (FMT)",
                    "timeFrame": "12 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Campylobacter PI-IBS defined by Rome III or Rome IV criteria\n* Non IBS-C\n* Moderate to severe symptoms defined by IBS-SSS\u2265175\n* Able to safely undergo and consent to colonoscopy\n\nExclusion Criteria\n\n* Immune deficiency or treatment with immunosuppressive medications\n* Severe bowel or medical disease precluding administration of bowel prep\n* Severe bowel or medical disease precluding colonoscopy with conscious sedation\n* Active cancer\n* Pregnant or lactating\n* Abdominal surgery (exception of fundoplication, hernia, appendectomy, cholecystectomy, caesarean section and hysterectomy)\n* Severe psychiatric disorder (HADS-A or D\\>16), or diagnosed alcohol or drug abuse disorder\n* New probiotics or treatment with antibiotics, NSAIDs (within 4 wks prior to study entry)\n* Use of treatments known to affect colonic motility (with exception of loperamide)\n* Diagnosed h/o bleeding disorder\n* Organic GI diseases (IBD, celiac disease, microscopic colitis)\n* Chronic kidney or liver disease\n* Absolute neutrophil count (ANC) \\<500 IU/ml",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "18 Years",
            "maximumAge": "70 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Margaret Breen-Lyles",
                    "role": "CONTACT",
                    "phone": "507-293-0237",
                    "email": "Breen-Lyles.Margaret@mayo.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Madhusudan Grover, MBBS",
                    "affiliation": "Mayo Clinic",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic in Minnesota",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Mayo Clinic Clinical Trials",
                    "url": "https://www.mayo.edu/research/clinical-trials"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000043183",
                    "term": "Irritable Bowel Syndrome"
                },
                {
                    "id": "D000013577",
                    "term": "Syndrome"
                },
                {
                    "id": "D000003967",
                    "term": "Diarrhea"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004194",
                    "term": "Disease"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000003109",
                    "term": "Colonic Diseases, Functional"
                },
                {
                    "id": "D000003108",
                    "term": "Colonic Diseases"
                },
                {
                    "id": "D000007410",
                    "term": "Intestinal Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000012817",
                    "term": "Signs and Symptoms, Digestive"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "asFound": "Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7159",
                    "name": "Diarrhea",
                    "asFound": "Diarrhea",
                    "relevance": "HIGH"
                },
                {
                    "id": "M25118",
                    "name": "Irritable Bowel Syndrome",
                    "asFound": "Irritable Bowel Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6336",
                    "name": "Colonic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6337",
                    "name": "Colonic Diseases, Functional",
                    "relevance": "LOW"
                },
                {
                    "id": "M10444",
                    "name": "Intestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15622",
                    "name": "Signs and Symptoms, Digestive",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                }
            ]
        }
    },
    "hasResults": false
}